With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Patients with colon cancer enrolled in CALGB 89803 (aka the trial that set a thousand secondary analyses in motion) who reported drinking daily artificially sweetened beverages like Coke lived longer without disease than their aspartame-free counterparts. | Guercio, PLoS One 2018